BioSpace News Archive

InMode Ltd. today provided an update regarding its business activities in light of the ongoing global health situation caused by the COVID-19. As of today, InMode’s Q1 2020 revenue from devices and consumables is in line with its target. Based

- In the months since the global public health crisis rose from a regional crisis to a global threat, drug makers large and small have scrambled to advance their best ideas for thwarting a pandemic. The crisis has catalyzed the development of novel vaccines across

- New Data to be Presented at NCCN 2020 Annual Conference - BeyondSpring Inc.

Pharmaceutics International, Inc., a leading Contract Development and Manufacturing Organization using Pharmaceutics Know-How™ to support the development and cGMP manufacture of a wide range of dosage forms, from sterile and non-sterile liquids to oral solid and semi-solid drug products, today announced the appointment of Sridhar Krishnan as Senior Vice President, Operations & Strategic Initiatives.

Physicians can now scan faster with the newly FDA-cleared Compressed SPEEDER technology from Canon Medical Systems USA, Inc.

So-Young International Inc., the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2019.

Organigram Holdings Inc., the parent company of Organigram Inc., a leading licensed producer of cannabis, is pleased to announce that the Company has received Health Canada’s approval for the licensing of the remainder of its Phase 5 expansion together with the renewal of its licenses for standard cultivation, standard processing and sale for medical purposes under the Cannabis Regulations.

BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, announced that the company will submit a De Novo application to the US Food and Drug Administration to obtain a market approval for the company’s antibiotic-releasing product CERAMENT G.

Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced Tommy Thomas has joined the Company as Vice President, Investor Relations.

NovaBay® Pharmaceuticals, Inc. unveils a rebrand for non-prescription Avenova, its antimicrobial lid and lash solution.